HLB Therapeutics Co.,Ltd. (115450.KQ)
KRW 10680.0
(-2.11%)
KRW 10680.0
(-2.11%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 8.22 Billion KRW | 93.78% |
| 2022 | -5.84 Billion KRW | 37.77% |
| 2021 | -14.48 Billion KRW | 11.27% |
| 2020 | -11.54 Billion KRW | 5.65% |
| 2019 | -12.87 Billion KRW | -297.24% |
| 2018 | 6.34 Billion KRW | 29.9% |
| 2017 | -4.07 Billion KRW | -12.96% |
| 2016 | -4.39 Billion KRW | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -1.17 Billion KRW | -122.23% |
| 2024 Q1 | -549.1 Million KRW | -0.36% |
| 2023 FY | - KRW | 93.78% |
| 2023 Q2 | 1.29 Billion KRW | 203.15% |
| 2023 Q3 | -211.02 Million KRW | -116.29% |
| 2023 Q4 | -526.03 Million KRW | -149.28% |
| 2023 Q1 | -1.25 Billion KRW | 52.28% |
| 2022 Q2 | -302.18 Million KRW | -106.33% |
| 2022 FY | - KRW | 37.77% |
| 2022 Q4 | -2.63 Billion KRW | 32.94% |
| 2022 Q3 | -3.92 Billion KRW | -1198.36% |
| 2022 Q1 | -146.46 Million KRW | 91.78% |
| 2021 Q4 | -1.78 Billion KRW | -18.13% |
| 2021 Q3 | -1.5 Billion KRW | 0.0% |
| 2021 FY | - KRW | 11.27% |
| 2020 FY | - KRW | 5.65% |
| 2019 FY | - KRW | -297.24% |
| 2018 FY | - KRW | 29.9% |
| 2017 FY | - KRW | -12.96% |
| 2016 FY | - KRW | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| HLB Co., Ltd. | -172.27 Billion KRW | 104.777% |
| iNtRON Biotechnology, Inc. | -6.23 Billion KRW | 231.997% |
| BINEX Co., Ltd. | 10.87 Billion KRW | 24.305% |
| Bioneer Corporation | 10.04 Billion KRW | 18.058% |
| Anterogen.Co.,Ltd. | -437.82 Million KRW | 1979.654% |
| MEDIPOST Co., Ltd. | -19.39 Billion KRW | 142.439% |
| CrystalGenomics, Inc. | -42.79 Billion KRW | 119.229% |
| Helixmith Co., Ltd | -53 Billion KRW | 115.526% |
| Chabiotech Co.,Ltd. | 70.08 Billion KRW | 88.258% |
| Medy-Tox Inc. | 32.69 Billion KRW | 74.832% |
| Peptron, Inc. | -12.65 Billion KRW | 165.053% |
| Amicogen, Inc. | 13.95 Billion KRW | 41.02% |
| Genexine, Inc. | -40.87 Billion KRW | 120.132% |
| LegoChem Biosciences, Inc. | -71.38 Billion KRW | 111.528% |
| ALTEOGEN Inc. | 440.04 Million KRW | -1770.183% |
| PharmaResearch Co., Ltd. | 104.25 Billion KRW | 92.106% |
| SillaJen, Inc. | -17.35 Billion KRW | 147.426% |
| JETEMA, Co., Ltd. | 11 Billion KRW | 25.238% |
| OliX Pharmaceuticals,Inc | -11.13 Billion KRW | 173.907% |
| Genomictree Inc. | -6.33 Billion KRW | 229.972% |
| MedPacto, Inc. | -32.6 Billion KRW | 125.237% |
| D&D Pharmatech | -9.05 Billion KRW | 190.855% |
| EASY BIO,Inc. | 24.32 Billion KRW | 66.166% |
| GI Innovation, Inc. | -51.33 Billion KRW | 116.033% |